Skip to main content

Table 1 Baseline characteristics of recently nonadherent patients who were subsequently initiated on depot and patients who were not

From: Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients

Variable

Depot Initiators (n = 39)

Non-Depot Initiators (n = 275)

Comparison P-value

Age at baseline, mean (SD)

34.7 (10.8)

40.8 (11.0)

.001

Gender, Male, n (%)

25 (64.1%)

157 (57.1%)

.489

Race, n (%)

  

.339

   White

17 (43.6%)

153 (55.8%)

 

   Black

19 (48.7%)

102 (37.2%)

 

   Other

3 (7.7%)

19 (6.9%)

 

Marital status, married, n (%)

13 (33.3%)

122 (44.9%)

.226

High school education or higher, n (%)

21 (53.8%)

182 (66.7%)

.150

Age at illness onset, mean (SD), years

17.7 (6.5)

19.2 (9.5)

.373

Health Insurance, n (%)

  

.771

   Medicaid

29 (74.4%)

180 (65.5%)

 

   Medicare

11 (28.2%)

95 (34.5%)

 

   Medicaid and Medicare

8 (20.5%)

54 (19.6%)

 

PANSS total score at enrollment, mean (SD)

70.3 (20.6)

68.8 (18.2)

.711

PANSS positive score at enrollment, mean (SD)

16.9 (6.6)

16.0 (6.1)

.516

PANSS negative score at enrollment, mean (SD)

18.8 (6.2)

17.5 (5.5)

.291

PANSS general psychopathology score at enrollment, mean (SD)

35.4 (11.4)

35.3 (10.0)

.970

Mental retardation/borderline IQ, n (%)

2 (5.1%)

5 (1.8%)

.211

Supervised housing, n (%)

4 (10.3%)

19 (6.9%)

.506